Abstract:The disease-specific accumulation of pathological proteins has long been the major focus of research in neurodegenerative diseases (ND), including Alzheimer's disease (AD) and related dementias (RD), but the recent identification of a multitude of genetic risk factors for ND in immune-associated genes highlights the importance of immune processes in disease pathogenesis and progression. Studies in animal models have characterized the local immune response to disease-specific proteins in AD and ADRD, but due to the complexity of disease processes and the co-existence of multiple protein pathologies in human donor brains, the precise role of immune processes in ND is far from understood. To better characterize the interplay between different extracellular and intracellular protein pathologies and the brain's intrinsic immune system in ND, we set out to comprehensively profile the local immune response in postmortem brain samples of individuals with "pure" beta-Amyloid and tau pathology (AD), "pure" α-Synuclein pathology in Lewy body diseases (LBD), as well as cases with Alzheimer's disease neuropathological changes (ADNC) and Lewy body pathology (MIX). Combining immunohistochemical profiling of microglia and digital image analysis, along with deep immunophenotyping using gene expression profiling on the NanoString nCounter® platform and digital spatial profiling on the NanoString GeoMx® platform we identified a robust immune activation signature in AD brain samples. This signature is maintained in persons with mixed pathologies, irrespective of co-existence of AD pathology and Lewy body (LB) pathology, while LBD brain samples with "pure" LB pathology exhibit an attenuated and distinct immune signature. Our studies highlight disease- and brain region-specific immune response profiles to intracellular and extracellular protein pathologies and further underscore the complexity of neuroimmune interactions in ND.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: to understand the characteristics of the immune response to pure protein pathology and mixed - protein pathology in different brain regions in neurodegenerative diseases (ND). Specifically, the author hopes to comprehensively describe the characteristics of the local immune response in post - mortem brain samples with "pure" β - amyloid (Aβ) and tau pathology (AD), "pure" α - synuclein pathology (LBD), and the co - existence of AD and LBD pathology (MIX). ### Main research questions: 1. **The influence of different types of protein pathology on the brain's innate immune system**: The research aims to explore how different types of protein pathology (such as Aβ, tau, and α - synuclein) affect the activation state of microglia and other immune cells in the brain. 2. **Differences in disease - specific and brain - region - specific immune responses**: By comparing immune responses in different disease contexts, to reveal the immune response patterns of specific diseases and specific brain regions. 3. **Changes in immune responses under mixed - pathology conditions**: To study the impact of mixed pathology (such as the co - existence of AD and LBD) on immune responses and understand the characteristics of immune activation in these complex situations. ### Research background: - The pathological features of neurodegenerative diseases such as Alzheimer's disease (AD) include Aβ plaques and tau tangles. Recent research has shown that the activation of the immune system (such as the activation of microglia) plays an important role in disease progression. - Animal model studies have shown that Aβ deposition can trigger a strong immune response, but in human patients, there are often cases of multiple protein pathologies co - existing, making the immune response more complex. - This study, by combining multiple technical means such as immunohistochemistry, gene expression analysis, and digital spatial analysis, has depicted in detail the characteristics of immune responses under different pathological conditions. ### Method overview: - **Sample selection**: Samples from 93 brain donors were selected from the University of Florida's Neurological Medicine Human Brain Bank and divided into four groups according to pathological characteristics: control group (Control), Alzheimer's disease group (AD), dementia with Lewy bodies group (LBD), and mixed - pathology group (MIX). - **Immunohistochemistry and quantitative analysis**: Microglia were labeled with Iba1 antibody and quantified through the QuPath platform. - **Gene expression analysis**: In - depth immunophenotyping was carried out using the NanoString nCounter® platform. - **Digital spatial analysis**: Digital spatial analysis was carried out using the NanoString GeoMx® platform to evaluate the immune microenvironment in different pathological regions. ### Expected results: - To reveal the characteristics of immune responses in different disease contexts (pure AD, pure LBD, and mixed pathology). - To discover the differences in immune responses in specific brain regions (such as the hippocampus, frontal cortex, occipital cortex, and midbrain). - To provide new insights into the complexity of immune responses in neurodegenerative diseases and provide theoretical support for future treatment strategies. Through these studies, the author hopes to better understand the role of the immune system in neurodegenerative diseases and provide a scientific basis for the development of new treatment methods for these diseases.

Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.

Immune attack: the role of inflammation in Alzheimer disease

Neuroimmune proteins can differentiate between tauopathies

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease

Neuroinflammation and protein pathology in Parkinson's disease dementia

CNS Immune Surveillance in Alzheimer’s Disease

Neuroinflammation in Alzheimer’s disease: microglial signature and their relevance to disease

Peripheral innate immunophenotype in neurodegenerative disease: blood-based profiles and links to survival

Spreading of pathology in neurodegenerative diseases: a focus on human studies

Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies

Integrative Network Analysis of Nineteen Brain Regions Identifies Molecular Signatures and Networks Underlying Selective Regional Vulnerability to Alzheimer’s Disease

Cell States and Interactions of CD8 T Cells and Disease-Enriched Microglia in Human Brains with Alzheimer's Disease

Amyloid-beta, alpha-synuclein and tau aggregated co-pathologies enhance neuropathology and neuroinflammation

In-vivo neuronal dysfunction by Aβ and tau overlaps with brain-wide inflammatory mechanisms in Alzheimer's disease

Identification of Immune Cells and Key Genes associated with Alzheimer's Disease

Integrative proteomics identifies a conserved Aβ amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer's disease

Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models

Differentially Expressed miRNAs in Age-Related Neurodegenerative Diseases: A Meta-Analysis

Distinct tau and alpha-synuclein molecular signatures in Alzheimer's disease with and without Lewy bodies and Parkinson's disease with dementia